Stomach dose-volume parameters and clinical factors predict acute toxicity in pancreatic cancer chemoradiotherapy
Gastrointestinal (GI) toxicity impedes dose escalation and likelihood of cure in chemoradiotherapy (CRT) for hepatobiliary malignancies. The risk of toxicity can depend on clinical and radiotherapy (RT) dose-volume metrics. We aimed to identify predictive factors using data from two prospective phas...
المؤلفون الرئيسيون: | Holyoake, D, Partridge, M, Hurt, C, Mukherjee, S, Hawkins, M |
---|---|
التنسيق: | Conference item |
منشور في: |
Elsevier
2017
|
مواد مشابهة
-
Stomach dose-volume predicts acute gastrointestinal toxicity in chemoradiotherapy for locally advanced pancreatic cancer
حسب: Holyoake, DLP, وآخرون
منشور في: (2018) -
Dosimetric parameters predict toxicity in chemoradiotherapy with nelfinavir for pancreatic cancer
حسب: Holyoake, D, وآخرون
منشور في: (2016) -
Modelling duodenum radiotherapy toxicity using cohort dose-volume-histogram data
حسب: Holyoake, D, وآخرون
منشور في: (2017) -
Systematic review and meta-analysis of small bowel dose–volume and acute toxicity in conventionally-fractionated rectal cancer radiotherapy
حسب: Holyoake, D, وآخرون
منشور في: (2019) -
Meta-analysis of toxicity and small-bowel radiotherapy dose-volume: “omnibus consequentia”
حسب: Holyoake, D, وآخرون
منشور في: (2018)